September 2025

Rio Tinto Limited has updated its dividend reinvestment plan details, announcing a DRP share price of AUD 121.97 and an allocation date of 2 October 2025 for its fully franked interim dividend.

Variscan Mines has successfully completed the majority of the second tranche of its $2.5 million capital raise, issuing over 330 million shares and nearly 200 million options to support its zinc-lead project in Spain.

Southern Palladium has responded to an ASX price query denying undisclosed information behind its recent share price rise, instead pointing to positive commodity price trends and ongoing project developments.

RAM Essential Services Property Fund (REP) reports a Q1 FY26 distribution in line with guidance and reaffirms its full-year yield target while progressing its strategic transition to a healthcare-focused REIT.

Future Metals NL has appointed seasoned resources executive Keith Bowes as Managing Director and CEO, aiming to accelerate development of its flagship Panton and Eileen Bore projects.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

Bio-Gene Technology Limited has addressed ASX concerns over the timing of its announcement on promising Flavocide efficacy data, confirming compliance with continuous disclosure rules after receiving final presentation materials from Purdue University.

Australian Clinical Labs has reached a $6.2 million settlement with the Australian Information Commissioner to resolve a Federal Court case stemming from a 2022 cyberattack on its newly acquired Medlab Pathology business.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.

Altamin Limited has launched a $6.46 million retail entitlement offer to fund exploration at its Lazio Project and maintain the Gorno Project. Eligible shareholders can subscribe to new shares at $0.025 each on a 45-for-100 basis.

Altamin Limited has launched a $6.46 million accelerated entitlement offer to fund exploration at its Lazio and Gorno projects, while excluding shareholders in certain jurisdictions due to regulatory constraints.

Altamin Limited has initiated a 45 for 100 accelerated pro-rata entitlement offer at $0.025 per share to raise up to AUD 6.46 million, supporting its Lazio and Gorno projects in Italy. The offer includes a strong institutional backing and opens to eligible retail shareholders across multiple jurisdictions.

Imagion Biosystems has completed the second tranche of its $3.5 million placement, raising $2.85 million to advance its proprietary MagSense® imaging technology targeting breast, prostate, and ovarian cancers.

AssetOwl Limited has locked in a $281,654 convertible note funding from a related party, adding to its financing options as it navigates shareholder approval and potential share dilution.

CurveBeam AI Limited has secured A$6.5 million in new capital to fuel global growth of its HiRise™ weight-bearing CT scanner, deepen its partnership with orthopaedic giant Stryker, and advance a potential strategic deal in China.

CurveBeam AI has secured A$6.5 million through an institutional placement and completed a €10 million vendor financing facility to accelerate sales of its HiRise™ CT scanner. The company is also progressing a strategic partnership in China and advancing surgical robot validation.

TT Investments, led by 360 Capital’s Executive Chairman Tony Pitt, has launched an unconditional off-market takeover bid for 360 Capital Group at an improved price of A$0.31 per security, signaling potential delisting and operational overhaul.

Burgundy Diamond Mines has been approved as eligible for up to CAD 150 million in emergency funding to sustain operations at its Ekati mine amid a sharp downturn in diamond prices caused by US tariffs. Trading in its securities remains suspended pending funding confirmation.

Mayne Pharma’s innovative oral contraceptive NEXTSTELLIS® has secured reimbursement under Australia’s Pharmaceutical Benefits Scheme, making it significantly more affordable and broadening contraceptive options nationwide.

Aeris Resources is advancing exploration at its Golden Plateau deposit with a significant drilling campaign aimed at expanding mineralisation and defining a new Exploration Target. The initiative could extend the life of its Cracow gold operations in Queensland.

Emu NL has bolstered its financial footing through a $590,000 rights issue and the sale of its Badja Gold Project, setting the stage for a maiden drilling program at its Yataga Copper Project. Leadership changes signal a new chapter as drilling preparations near completion.

HITIQ Ltd has raised $250,000 through a premium-priced placement and secured a $1.4 million RDTI loan facility to support its pivot towards consumer concussion management technology.

RocketDNA Ltd has landed a $450,000 contract with BHP Mitsubishi Alliance to operate three SurveyBot drone units over nine months, reinforcing its foothold in the mining sector.

Australian Unity Limited has appointed Kelly Bayer Rosmarin as its next Group Managing Director and CEO, succeeding Rohan Mead after his 21-year tenure. Bayer Rosmarin’s leadership is expected to drive the company’s strategic transformation and growth in wellbeing services.